Approximately 70% to 75% of breast cancers highly express estrogen receptor alpha (ERα), and most ERα-positive breast cancers are dependent on estrogen signaling, which initially results in a favorable response to endocrine therapy [35]. This evidence concerns the gene ESR1 and breast cancer.